drugset / Trial / NCT01412073

Control of Blood Loss During Caesarean Section

NCT01412073

Phase 3 Completed 600 enrolled Cairo University
RandomizedParallel-groupSingle-blindPrevention

Summary

trial of 3 protocols to determine the best one to control blood loss during caesarean section

Timeline

Start
2011-09
Primary completion
2014-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 800 ug Other
Comparator Oxytocin Peptide 5 iu Intravenous
Comparator Oxytocin Peptide 30 iu Intravenous

Indications

No indication recorded.